Skip to main content
. 2017 Oct 30;22(2):728–737. doi: 10.1111/jcmm.13407

Figure 1.

Figure 1

Application of extracellular vesicles (EVs) as therapeutic vector based on its natural content or as carriers of drug and nucleic acid in acute and chronic kidney injury is described in recent studies.